— Know what they know.
Not Investment Advice

0YAY.IL IOB

Vitrolife AB
1W: -1.6% 1M: -2.5% YTD: +8.0%
kr 92.78 ($9.24)
-0.23 (-0.24%)
 
Weekly Expected Move ±3.4%
kr 86 kr 90 kr 93 kr 96 kr 99
IOB · Healthcare · Medical - Devices · Tech Score Neutral · Power 57 · kr 12.6B mcap · 70M float · 0.022% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Capkr 12.6B ($1.3B)
52W Range84.75-151.65
Volume909
Avg Volume15,398
Beta1.87
Dividendkr 1.10
Analyst Ratings
No analyst coverage
Company Info
CEOBronwyn Brophy O'Connor
Employees1,151
SectorHealthcare
IndustryMedical - Devices
IPO Date2013-07-18
Gustaf Werners gata 2
Gothenburg, VG 421 32
SE
46 3 17 21 80 00
About Vitrolife AB

Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; Americas; and Asia. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms